These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Obsessive-compulsive disorder in children and adolescents. Krebs G; Heyman I Arch Dis Child; 2015 May; 100(5):495-9. PubMed ID: 25398447 [TBL] [Abstract][Full Text] [Related]
25. Obsessive-compulsive disorder in elderly patients. Jackson CW Drugs Aging; 1995 Dec; 7(6):438-48. PubMed ID: 8601051 [TBL] [Abstract][Full Text] [Related]
26. Improvement of obsessions and compulsions with clozapine in an individual with schizophrenia. Tibbo P; Gendemann K Can J Psychiatry; 1999 Dec; 44(10):1049-50. PubMed ID: 10637686 [No Abstract] [Full Text] [Related]
27. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis. Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122 [TBL] [Abstract][Full Text] [Related]
28. [Obsessive-compulsive disorder and schizophrenia]. Denda K Ryoikibetsu Shokogun Shirizu; 2003; (38):459-63. PubMed ID: 12877026 [No Abstract] [Full Text] [Related]
29. Relationship between obsessive-compulsive disorder and chaos. Kubota S; Sakai K Med Hypotheses; 2002 Jul; 59(1):16-23. PubMed ID: 12160676 [TBL] [Abstract][Full Text] [Related]
30. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Pigott TA; Seay SM J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of clomipramine in obsessive-compulsive disorder. Howland RH Anxiety; 1996; 2(1):56-7. PubMed ID: 9160602 [No Abstract] [Full Text] [Related]
32. Exploring the minimal important difference in the treatment of paediatric obsessive-compulsive disorder using selective serotonin reuptake inhibitors. Cohen SE; Denys DAJP; Mattila TK; Storosum BWC; de Boer A; Zantvoord JB BMJ Ment Health; 2024 Jun; 27(1):. PubMed ID: 38901870 [No Abstract] [Full Text] [Related]
33. [Physiopathology of obsessive-compulsive disorder--special reference to aspects of the neurochemistry]. Seishin Shinkeigaku Zasshi; 2009; 111(7):796-801. PubMed ID: 19999279 [No Abstract] [Full Text] [Related]